
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Bioinformation</journal-id><journal-id journal-id-type="iso-abbrev">Bioinformation</journal-id><journal-id journal-id-type="publisher-id">Bioinformation</journal-id><journal-title-group><journal-title>Bioinformation</journal-title></journal-title-group><issn pub-type="epub">0973-2063</issn><publisher><publisher-name>Biomedical Informatics</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">31312074</article-id><article-id pub-id-type="pmc">6614126</article-id><article-id pub-id-type="publisher-id">97320630015380</article-id><article-id pub-id-type="doi">10.6026/97320630015380</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Molecular docking and ADMET analysis of hydroxamic acids as HDAC2 inhibitors</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Alsawalha</surname><given-names>Murad</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Rao Bolla</surname><given-names>Srinivasa</given-names></name><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name><surname>Kandakatla</surname><given-names>Naresh</given-names></name><xref ref-type="aff" rid="A3">3</xref></contrib><contrib contrib-type="author"><name><surname>Srinivasadesikan</surname><given-names>Venkatesan</given-names></name><xref ref-type="aff" rid="A4">4</xref><xref ref-type="aff" rid="A5">5</xref></contrib><contrib contrib-type="author"><name><surname>Veeraraghavan</surname><given-names>Vishnu Priya</given-names></name><xref ref-type="aff" rid="A6">6</xref></contrib><contrib contrib-type="author"><name><surname>Surapaneni</surname><given-names>Krishna Mohan</given-names></name><xref ref-type="aff" rid="A7">7</xref><xref ref-type="corresp" rid="COR1">*</xref></contrib><aff id="A1"><label>1</label>Department of Chemical and Process Engineering Technology, Jubail Industrial College (JIC), P.O. Box 10099, Jubail Industrial City 31961,Kingdom of Saudi Arabia</aff><aff id="A2"><label>2</label>Department of Anatomy, College of Medicine, Imam Abdulrahman Bin Faisal University, P.O.Box 2114,Dammam 31451, Kingdom of Saudi Arabia</aff><aff id="A3"><label>3</label>Department of Chemistry, Sathyabama University, Jeppiaar Nagar, Chennai - 600 119, Tamil Nadu, India, 600119</aff><aff id="A4"><label>4</label>Department of Applied Chemistry, National Chiao Tung University, Hsinchu, 300, Taiwan</aff><aff id="A5"><label>5</label>5Division of Chemistry,Department of Sciences and Humanities, Vignan's Foundation for Science, Technology and Research University, Vadlamudi, 522 213,Guntur, Andhra Pradesh, India</aff><aff id="A6"><label>6</label>6Department of Biochemistry, Saveetha Dental College, Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha University, 162, P. H. Road, Velappanchavadi, Chennai - 600 077, Tamil Nadu, India</aff><aff id="A7"><label>7</label>7Department of Medical Biochemistry, College of Applied Medical Sciences in Jubail (CAMSJ), Imam Abdulrahman Bin Faisal University, Jubail Industrial City 35816, Kingdom</aff></contrib-group><author-notes><corresp id="COR1"><label>*</label>Krishna Mohan Surapaneni: <email>skmohan@iau.edu.sa</email></corresp></author-notes><pub-date pub-type="collection"><year>2019</year></pub-date><pub-date pub-type="epub"><day>30</day><month>5</month><year>2019</year></pub-date><volume>15</volume><issue>6</issue><fpage>380</fpage><lpage>387</lpage><history><date date-type="received"><day>30</day><month>4</month><year>2019</year></date><date date-type="accepted"><day>5</day><month>5</month><year>2019</year></date></history><permissions><copyright-statement>&#x000a9; 2019 Biomedical Informatics</copyright-statement><copyright-year>2019</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0/"><license-p>This is an Open Access article which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. This is distributed under the terms of the Creative Commons Attribution License.</license-p></license></permissions><abstract><p>Histone deacetylase (HDAC2) belongs to the hydrolase family and a promising target for cancers. We reported 96 hydroxamic compounds
optimized using hydrogen-donors, hydrophobic and electron withdrawing groups followed by molecular docking studies. The optimized
compounds show good LibDock score and H-bond interaction in the active site of HDAC2. We selected 20 compounds as the best HDAC2
inhibitors based on the LibDock score, binding energy and hydrogen bonding. ADMET predictions on these compounds show good
absorption, BBB penetration and no liver toxicity. We subsequently report four compounds selected as best HDAC2 inhibitors based on the
LibDock, binding energy, H-bonding and ADMET properties.</p></abstract><kwd-group><kwd>ADMET</kwd><kwd>histone deacetylase 2</kwd><kwd>hydroxamic acids</kwd><kwd>molecular docking</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>Background</title><p>
Chromatin structure of histone has two forms such as Histone
acetylases (HATs) and Histone deacetylases (HDACs). The
acetylation status of histone operated by histone acetylases and
histone deacetylases, which are in equilibrium <xref rid="R01" ref-type="bibr">1</xref>.The main
function of HDAC is deacetylation of e-amino groups of lysine
located near the amino terminal of core histone proteins and restore
positive charge on lysine residue, which results in tightening of
nucleosome structure and gene silencing <xref rid="R02" ref-type="bibr">2</xref>. HDACs not only
deacetylate the histone proteins, but also deacetylate non-histone
proteins, such as p53 and GATA-1 <xref rid="R03" ref-type="bibr">3</xref>. Histone deacetylase protein
belongs to the hydrolase family and classified into two classes on
the basis of sequence similarity, class I has four isomers of HDAC1-
3, and HDAC8 and are related to yeast Rpd3 gene, class II has six
isomers of HDAC4-7 and HDAC9-10 and are related to Hda1 and
class I and II operated by zinc dependent mechanism <xref rid="R04" ref-type="bibr">4</xref>. Histone
deacetylases (HDACs) control the gene expression and cellular
signalling and histone deacetylases 2 (HDAC2) is over expressed in
solid tumors including colon cancer, lung cancer, cervical
carcinoma, breast cancer, and kidney/cervix cancer and also in
Alzheimer's disease <xref rid="R05" ref-type="bibr">5</xref>-<xref rid="R07" ref-type="bibr">7</xref>. Several natural and synthetic derivatives
have been identified to be able to inhibit the activity of the HDACs.</p><p>HDAC inhibitors (HDACi) arrest cell growth and leads to
differentiation and apoptosis in tumor cells. HDACi can be divided
into several structural classes including hydroxamic acids, cyclic
peptides, aliphatic acids and benzamides etc. <xref rid="R08" ref-type="bibr">8</xref>-<xref rid="R09" ref-type="bibr">9</xref>. Naturally
identified Hydroxamic acid HDAC inhibitor was Trichostatin A
(TSA) and SAHA (Suberoylanilide hydroxamic acid or Vorinostat
(Zolinza)) is structurally similar to TSA was first HDAC inhibitor
approved for the treatment of refractory cutaneous T-cell
lymphoma by Food and Drug Administration (FDA) in October
2006 <xref rid="R10" ref-type="bibr">10</xref>-<xref rid="R11" ref-type="bibr">11</xref>. The compounds with radio sensitizing properties were
found to be effective in the clinical application as they are cell
specific <xref rid="R12" ref-type="bibr">12</xref>. Research on the SAHA as HDAC inhibitor for the
treatment of hematologic and solid tumors is found to be efficient
<xref rid="R13" ref-type="bibr">13</xref>. Some studies found that HDAC inhibitors can be used for
targeting the radio resistant cancers <xref rid="R14" ref-type="bibr">14</xref>. Trail (Apo2L, TNFSF10) as
a mediator tigers the tumor cell death in acute myeloid leukemia
<xref rid="R15" ref-type="bibr">15</xref>. Finding the specific HDACi for the individual HDAC is an
important goal since HDACs are found to maintain different
biological activities. Drug design is one of the emerging and
important fields for drug discovery. The studies help in developing
novel structures and potent drug molecules used for the drug
therapies <xref rid="R16" ref-type="bibr">16</xref>. Studies on Uveal melanoma concluded that HDAC
inhibitors provoked morphological differentiation which hindered
the growth of tumor <xref rid="R17" ref-type="bibr">17</xref>. SAHA is a low toxic drug that was
docked to get 12 different versions by drug modification and was
screened. These were evaluated and were found to exhibit more
potency and better affinity than the SAHA <xref rid="R18" ref-type="bibr">18</xref>. In order to develop
best class of drugs, the innovative approach for drug designing, is
opted by the researchers in recent times <xref rid="R19" ref-type="bibr">19</xref>. Optimization of
HDAC2 inhibitors of hydroxamic acid was reported previously <xref rid="R20" ref-type="bibr">20-
21</xref> and in this study we optimized hydroxamic acid group. Based
on our previous QSAR and pharmacophore studies, molecular
docking, binding energy and ADMET studies were carried out.</p></sec><sec id="s2"><title>Methodology</title><sec id="s2a"><title>Data set:</title><p>Hydroxamic acids were optimized to improve the inhibitory
activity towards HDAC2 protein. SAHA was chosen as reference
structure to design new set of compounds. Total 96 compounds
were designed based on the 3D-QSAR model on hydroxamic acid
(<xref ref-type="fig" rid="F1">Figure 1</xref>) <xref rid="R22" ref-type="bibr">22</xref>. Hydroxamic acid derivatives were optimized with
H-bond donors (OH, CH3, CH=CH2, Ph), hydrophobic
(hydrocarbons - Pyrrole, Furan, Thiophene, Imidazole, Oxazole,
Isooxzole, Benzene, Ph-NO2, Ph-COCH3, Ph-CCl3, Aniline, Indole,
Pyridine and Pyrimidine) and electron withdrawing groups (NO2,
NCH3, SO3CH3, COCl, COOH, COCH3, COH, Br, Cl and F) were
listed in <xref rid="T1" ref-type="table">Table 1</xref>. Molecular docking analysis performed on these
molecules to investigate for better HDAC2 inhibitors. All ligands
were sketched using ISIS draw and given as input file in prepare
ligand module in Discovery studio (DS). This generated 3Dstructures,
tatuomers, and isomers and filtered the ligands by
Lipinski rule of five. After applying the force fields on ligands the
structures were minimized for lowest energy.</p></sec><sec id="s2b"><title>Protein preparation and docking:</title><p>The crystal structure of HDAC2 (PDB ID: 3MAX) was downloaded
from protein database (http://www.rcsb.org/pdb). The protein
preparation was carried out in DS by removing water molecules
and co-crystallized ligand further applying force filed parameter
CHARMm to protein. The receptor binding sites were searched
using flood filling algorithm. Docking calculations carried out
using LibDock program implemented in discovery studio <xref rid="R01" ref-type="bibr">23</xref>. The
15 - site sphere was selected using coordinates in predefined
binding site for docking studies. The 500 binding site features, so
call 'HotSpots' in binding site spheres were determined using a
grid placed into the binding site with polar and apolar probes. The
conformations of ligands poses were generated using FAST method
and then placed into the binding site sphere. The docking poses
were pruned and optimized. Final best optimized compounds were
selected based on the LibDock score and H-bonds and the results
were compared with the SAHA compound.</p><p>In 3D molecular docking studies, the candidate compound docked
into the target protein and provides a variety of structural
information such as hydrogen bonding interaction, electrostatic
interaction, and molecular surface complementary and so on. The
binding energy of complex calculated using Eq. 1, which gives the
better understanding of binding affinity of the docked complex.</p><p>&#x00394;E = E complex - (E enzyme + E ligand) (Eq. 1)</p><p>Best resulted compounds from molecular docking studies were
considered for binding energy calculations. The energies of each
inhibitor and HDAC2 were calculated by semi-empirical method
PM6 <xref rid="R24" ref-type="bibr">24</xref>. The energy association of each ligand (&#x00394;E) was estimated
by three types of calculations such as (i) single point energy
calculations of active site residues of protein and inhibitor complex
(E complex) (ii) energy calculation of chosen active site residue of
protein (E enzyme)and (iii) single point energy calculation on ligand (E
ligand). The PM6 method used in this study because of the size of the
complex and also the binding/interaction energies reported using
PMx method shows good results <xref rid="R25" ref-type="bibr">25</xref>-<xref rid="R30" ref-type="bibr">30</xref>. The quantum chemical
calculations were performed using GAUSSIAN 09 <xref rid="R31" ref-type="bibr">31</xref>.</p></sec><sec id="s2c"><title>ADMET:</title><p>ADMET (Absorption, Distribution, Metabolism, and Excretion): In
drug discovery many potential drugs failed in clinical trials or late
drug discovery process, due to poor drug like properties and
adverse side effects. In the current investigation, all the optimized
hydroxamic acid compounds were subjected to ADMET studies to
make sure toxicity risks and drug-relevant properties of molecules
which are key factors, to determine drug-likeness of lead molecules.
ADMET studies were conducted on selected lead compounds using
Discovery Studio (Accelrys, San Diego, CA, USA). This module
uses six mathematical models, to quantitatively predict properties
by a set of rules/keys that specify threshold ADMET characteristics
for the chemical structure of the molecules based on the available
drug information.</p></sec></sec><sec id="s3"><title>Results and Discussion:</title><sec id="s3a"><title>Molecular docking:</title><p>Molecular docking studies were carried out on 96 designed
hydroxamic acids from 3D-QSAR studies. The HDAC2 protein has
3 chains (Chain A, B and C), chain A is selected for docking studies
<xref rid="R20" ref-type="bibr">20</xref>, <xref rid="R32" ref-type="bibr">32</xref>. LibDock score, binding energy and H bonding considers
for selection of best HDAC2 inhibitors. SAHA is chosen as
reference compound for comparing the docking score of
compounds. SAHA has the LibDock score of 126.37 dock score and
4 hydrogen bond interactions with ARG39(2), HIS183, GLY305,
GLY154 amino acids and pi-pi interaction with PHE155. About 62
compounds among 96 were shown good docking score than SAHA,
top listed 20 compounds with LibDock score and H-bonds were
shown in <xref rid="T2" ref-type="table">Table 2</xref>. Based on molecular docking and H-bond
interaction four compounds are selected as best inhibitor of
HDAC2 protein. H34 (3-(8-oxo-8-(phenylamino) octanamido)
benzoyl chloride) has the LibDock score of 153.22 and three Hbonds
with ARG39, HIS146, GLY142 and pi-pi bond with ARG39
shown in <xref ref-type="fig" rid="F2">Figure 2 (b)</xref>, It shows oxygen of N-hydroxyl group forms
H-bonds with HIS146, oxygen of formamide forms H-bonds with
GLY142 and ARG39. LibDock score 145.94 for H81 (N1-(3-(pyridin-
2-yl)phenyl)-N8-vinyloctanediamide) with three H-bonds with
ARG39, TYR308, HIS146 and pi-pi bond with ARG39 shown in
<xref ref-type="fig" rid="F1">Figure 2(c)</xref>, it shows oxygen of N-hydroxyl group forms H-bonds
with HIS146, oxygen of formamide forms H-bond with TYR308 and
ARG39. H43 (N1-hydroxy-N8-(3-(thiophen-2-yl) phenyl)
octanediamide) has LibDock score of 145.85 and five H-bonds with
ARG39, GLN265 (2), HIS145, ASP181, ASP104 and pi-pi bond with
ARG39 shown in <xref ref-type="fig" rid="F1">Figure 2(d)</xref>, It shows oxygen of N-hydroxyl group
forms H-bonds with ASP104, oxygen of formamide forms H-bonds
with ASP181, HIS145 and GLN265, thiophene of sulphar forms
bonds with ARG39. H30 (N1-(3-fluorophenyl)-N8-vinyl
octanediamide) has LibDock score of 143.00 with four H-bonds
ARG39 (2), HIS183, GLY305, TRP140 and pi-pi bond with PHE155
shown in <xref ref-type="fig" rid="F1">Figure 2 (e)</xref>, It shows oxygen of N-hydroxyl group forms
H-bonds with ARG39, GLY305 and TRP40 and oxygen of
formamide forms H-bond with HIS183.The result shows that Nhydroxyl
group, which is an important group and forms
interactions with the HDAC2.</p></sec><sec id="s3b"><title>Binding Energy calculation:</title><p>Binding energy calculations were performed on the best 20
Compounds which have good docking score and H-bond
interaction and results are listed in <xref rid="T2" ref-type="table">Table 2</xref>. In order to compare the
obtained Binding energy (&#x00394;E), calculations also performed on
active HDAC2 inhibitors (SAHA). <xref rid="T2" ref-type="table">Table 2</xref> shows the binding
energy calculation (PM6) of HDAC2-inhibitor complexes. The
binding energy of active HDAC2 inhibitors SAHA is -33.25
kcal/mol, and the binding energy of selected four compounds as
(3-(8-oxo-8-(phenylamino) octanamido)benzoyl chloride (H34) (-
39.53 kcal/mol), N1-(3-(pyridin-2-yl)phenyl)-N8-
vinyloctanediamide (H81) (-56.08 kcal/mol), N1-hydroxy-N8-(3-
(thiophen-2-yl)phenyl) octanediamide (H43) (-43.21 kcal/mol), N1-
(3-fluorophenyl)-N8-vinyloctanediamide) (-35.76 kcal/mol), it
shows these compounds have smaller binding energy than active
HDAC2 inhibitors and were suggesting an inhibitors of
HDAC2.The compounds, which are having hydrogen bond
interactions with ARG, HIS, TYR active residues shows smaller
binding energies. This implies that the active site residues ARG,
HIS, TYR are become more favourable to the binding of HDAC2
inhibitors.</p></sec><sec id="s3c"><title>ADMET:</title><p>ADMET predictions were carried out to evaluate drug likeness of
top 20 selected compounds and the properties were reported in
<xref rid="T3" ref-type="table">Table 3</xref> together with biplot <xref ref-type="fig" rid="F1">Figure 3</xref>. The pharmacokinetic profiles
of selected compounds were predicted by means of six precalculated
ADMET model provided by Discovery studio. <xref ref-type="fig" rid="F1">Figure 3</xref>
bi plot shows two analogous 95% and 99% confidence ellipse
corresponding to HIA and BBB models. PSA have inverse
relationship with human intestinal absorption and thus cell wall
permeability. The log P used to estimate the lipophilicity, thus the
information of H-bonding characteristics as obtained by calculating
PSA could be taken into consideration along with logP calculation.
The model with descriptors AlogP98 and PSA 2D with a bi-plot
comprising 95% and 99% confidence ellipses was considered for the
accurate prediction for the cell permeability of compounds.
Selected 20 compounds had a good adsorption prediction for
metabolism. In toxicity evaluation except H32 all compounds
displayed CYP2D6 inhibiting and hepatotoxicity, suggesting that
these compounds have no toxicity in the liver. Blood brain barrier
(BBB) penetration showed that 10 compounds have good
penetration; 8 compounds have low penetration and 2 compounds
have undefined penetration;10 compounds may suitable for central
nerve system therapy. Four compounds (3-(8-oxo-8-
(phenylamino)octanamido)benzoyl chloride (H34); N1-(3-(pyridin-
2-yl)phenyl)-N8-vinyloctanediamide (H81);N1-hydroxy-N8-(3-
(thiophen-2-yl)phenyl)octanediamide (H43); N1-(3-fluorophenyl)-
N8-vinyloctanediamide) (H30) were selected as potential
compounds based on the LibDock, binding energy, H bonding and
ADMET properties.</p></sec></sec><sec id="s5"><title>Conclusion</title><p>It is of interest to identify better inhibitors for HDAC2. Here, we
report the binding of 4 HDAC2 inhibitors with optimal LibDock
score, binding energy and hydrogen-bonds. It is further noted by
ADMET analysis that these compounds have good absorption, less
toxic in the human liver and BBB penetration and may therefore
suggest as HDAC2 inhibitors.</p></sec></body><back><fn-group><fn id="FN" fn-type="other"><p><bold>Edited by P Kangueane</bold></p></fn></fn-group><fn-group><fn id="FN1" fn-type="other"><p><bold>Citation: </bold>Alsawalha <italic>et al. </italic> Bioinformation 15(6): 380-387 (2019)</p></fn></fn-group><ref-list><title>References</title><ref id="R01"><label>01</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Monneret</surname><given-names>C</given-names></name></person-group><source> Eur J Med Chem</source><year>2005</year><volume>40</volume><fpage>1</fpage><pub-id pub-id-type="pmid">15642405</pub-id></element-citation></ref><ref id="R02"><label>02</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mai</surname><given-names>A</given-names></name><etal/></person-group><source> J Med Chem</source><year>2002</year><volume>45</volume><fpage>1778</fpage><pub-id pub-id-type="pmid">11960489</pub-id></element-citation></ref><ref id="R03"><label>03</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Juan</surname><given-names>LJ</given-names></name><etal/></person-group><source> J Biol Chem</source><year>2000</year><volume>275</volume><fpage>20436</fpage><pub-id pub-id-type="pmid">10777477</pub-id></element-citation></ref><ref id="R04"><label>04</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bieliauskas</surname><given-names>AV</given-names></name><name><surname>Pflum</surname><given-names>MK</given-names></name></person-group><source>Chem Soc</source><year>2008</year><volume>37</volume><fpage>1402</fpage><pub-id pub-id-type="pmid">18568166</pub-id></element-citation></ref><ref id="R05"><label>05</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gregoretti</surname><given-names>IV</given-names></name><etal/></person-group><source>Journal of Molecular Biology</source><year>2004</year><volume>338</volume><fpage>17</fpage><pub-id pub-id-type="pmid">15050820</pub-id></element-citation></ref><ref id="R06"><label>06</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kr&#x0fffd;amer</surname><given-names>OH</given-names></name></person-group><source>Trends in Pharmacological Sciences</source><year>2009</year><volume>30</volume><fpage>647</fpage><pub-id pub-id-type="pmid">19892411</pub-id></element-citation></ref><ref id="R07"><label>07</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnstone</surname><given-names>RW</given-names></name></person-group><source> Nature Reviews Drug Discovery</source><year>2002</year><volume>1</volume><fpage>287</fpage><pub-id pub-id-type="pmid">12120280</pub-id></element-citation></ref><ref id="R08"><label>08</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kilgore</surname><given-names>M</given-names></name><etal/></person-group><source> Neuro psycho pharmacology</source><year>2010</year><volume>35</volume><fpage>870</fpage><pub-id pub-id-type="pmid">20010553</pub-id></element-citation></ref><ref id="R09"><label>09</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kapustin</surname><given-names>GV</given-names></name><etal/></person-group><source> Org Lett</source><year>2003</year><volume>5</volume><fpage>3053</fpage><pub-id pub-id-type="pmid">12916979</pub-id></element-citation></ref><ref id="R10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blum</surname><given-names>KA</given-names></name><etal/></person-group><source>Br J Haematol</source><year>2009</year><volume>147</volume><fpage>507</fpage><pub-id pub-id-type="pmid">19747365</pub-id></element-citation></ref><ref id="R11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marks</surname><given-names>PA</given-names></name><name><surname>Breslow</surname><given-names>R</given-names></name></person-group><source>Nature Biotechnology</source><year>2007</year><volume>25</volume><fpage>84</fpage><pub-id pub-id-type="pmid">17211407</pub-id></element-citation></ref><ref id="R12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jung</surname><given-names>M</given-names></name><etal/></person-group><source> Radiat Res</source><year>2005</year><volume>163</volume><fpage>488</fpage><pub-id pub-id-type="pmid">15850409</pub-id></element-citation></ref><ref id="R13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kelly</surname><given-names>WK</given-names></name><name><surname>Marks</surname><given-names>PA</given-names></name></person-group><source>Nature Clinical Practice Oncology</source><year>2005</year><volume>2</volume><fpage>150</fpage><pub-id pub-id-type="pmid">16264908</pub-id></element-citation></ref><ref id="R14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y</given-names></name><etal/></person-group><source> Radiation Research</source><year>2004</year><volume>161</volume><fpage>667</fpage><pub-id pub-id-type="pmid">15161353</pub-id></element-citation></ref><ref id="R15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nebbioso</surname><given-names>A</given-names></name><etal/></person-group><source> Nature Medicine</source><year>2005</year><volume>11</volume><fpage>77</fpage><pub-id pub-id-type="pmid">15619633</pub-id></element-citation></ref><ref id="R16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Melagraki</surname><given-names>G</given-names></name><etal/></person-group><source> Mol Divers</source><year>2009</year><volume>13</volume><fpage>301</fpage><pub-id pub-id-type="pmid">19205914</pub-id></element-citation></ref><ref id="R17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Landreville</surname><given-names>S</given-names></name><etal/></person-group><source> Clin Cancer Res</source><year>2012</year><volume>18</volume><fpage>408</fpage><pub-id pub-id-type="pmid">22038994</pub-id></element-citation></ref><ref id="R18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tambunan</surname><given-names>USF</given-names></name></person-group><source>BMC Bioinformatics</source><year>2011</year><volume>12</volume><fpage>S23</fpage><pub-id pub-id-type="pmid">22373132</pub-id></element-citation></ref><ref id="R19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mills</surname><given-names>JS</given-names></name><name><surname>Showell</surname><given-names>GA</given-names></name></person-group><source>Expert Opinion on Investigational Drugs</source><year>2004</year><volume>13</volume><fpage>1149</fpage><pub-id pub-id-type="pmid">15330746</pub-id></element-citation></ref><ref id="R20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walkinshaw</surname><given-names>DR</given-names></name><name><surname>Yang</surname><given-names>XJ</given-names></name></person-group><source>Curr Oncol</source><year>2008</year><volume>15</volume><fpage>237</fpage><pub-id pub-id-type="pmid">19008999</pub-id></element-citation></ref><ref id="R21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naresh</surname><given-names>K</given-names></name><etal/></person-group><source>Bangladesh J Pharmacol</source><year>2013</year><volume>8</volume><fpage>328</fpage></element-citation></ref><ref id="R22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naresh</surname><given-names>K</given-names></name><etal/></person-group><source> International conference on Engineering and physicalsciences</source><year>2015</year></element-citation></ref><ref id="R23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Diller</surname><given-names>DJ</given-names></name><name><surname>Merz</surname><given-names>ML</given-names></name></person-group><source>Proteins: Structure Function, andGenetics</source><year>2001</year><volume>43</volume><fpage>113</fpage><pub-id pub-id-type="pmid">11276081</pub-id></element-citation></ref><ref id="R24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stewart</surname><given-names>JJP</given-names></name></person-group><source>J Mol Model</source><year>2007</year><volume>13</volume><fpage>1173</fpage><pub-id pub-id-type="pmid">17828561</pub-id></element-citation></ref><ref id="R25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Araujo</surname><given-names>PMM</given-names></name><etal/></person-group><source> Chem Phys Lett</source><year>2014</year><volume>591</volume><fpage>273</fpage></element-citation></ref><ref id="R26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anisimov</surname><given-names>VM</given-names></name><name><surname>Cavasotto</surname><given-names>CN</given-names></name></person-group><source>J Comput Chem</source><year>2011</year><volume>1</volume><fpage>1</fpage><pub-id pub-id-type="pmid">21484840</pub-id></element-citation></ref><ref id="R27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dubey</surname><given-names>KD</given-names></name><name><surname>Ojha</surname><given-names>RP</given-names></name></person-group><source>J Biol Phys</source><year>2011</year><volume>37</volume><fpage>69</fpage><pub-id pub-id-type="pmid">22210962</pub-id></element-citation></ref><ref id="R28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nunthaboot</surname><given-names>N</given-names></name><etal/></person-group><source> J Phys Chem B </source><year>2008</year><volume>112</volume><fpage>15837</fpage><pub-id pub-id-type="pmid">19053889</pub-id></element-citation></ref><ref id="R29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xiong</surname><given-names>YZ</given-names></name><name><surname>Chen</surname><given-names>PY</given-names></name></person-group><source>J Mol Model</source><year>2008</year><volume>14</volume><fpage>1083</fpage><pub-id pub-id-type="pmid">18663490</pub-id></element-citation></ref><ref id="R30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pinto da Silva</surname><given-names>L</given-names></name><etal/></person-group><source>Chem Phys Lett</source><year>2012</year><volume>543</volume><fpage>137</fpage></element-citation></ref><ref id="R31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frisch</surname><given-names>MJ</given-names></name><etal/></person-group><source>Gaussian, Inc Wallingford CT</source><year>2009</year></element-citation></ref><ref id="R32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naresh</surname><given-names>K</given-names></name><name><surname>Geetha</surname><given-names>R</given-names></name></person-group><source>Advances in Bioinformatics</source><year>2014</year><fpage>p812148</fpage><pub-id pub-id-type="pmid">25525429</pub-id></element-citation></ref></ref-list></back><floats-group><table-wrap id="T1" position="float"><label>Table 1</label><caption><title>Different substitutions used in hydroxamic acid derivatives</title></caption><table frame="hsides" rules="groups"><thead><tr><td rowspan="1" colspan="1">
</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">R1</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">R1</td></tr><tr><td rowspan="1" colspan="1">Compd No</td><td rowspan="1" colspan="1">X</td><td rowspan="1" colspan="1">(EW, hydrocarbon)</td><td rowspan="1" colspan="1">Compd No</td><td rowspan="1" colspan="1">X</td><td rowspan="1" colspan="1">(EW, hydrocarbon)</td></tr></thead><tbody><tr><td rowspan="1" colspan="1">H1</td><td rowspan="1" colspan="1">N-OH</td><td rowspan="1" colspan="1">NO2</td><td rowspan="1" colspan="1">H49</td><td rowspan="1" colspan="1">N-OH</td><td rowspan="1" colspan="1">Ph-COCH3</td></tr><tr><td rowspan="1" colspan="1">H2</td><td rowspan="1" colspan="1">N-OH</td><td rowspan="1" colspan="1">NCH3</td><td rowspan="1" colspan="1">H50</td><td rowspan="1" colspan="1">N-OH</td><td rowspan="1" colspan="1">Ph-CCl3</td></tr><tr><td rowspan="1" colspan="1">H3</td><td rowspan="1" colspan="1">N-OH</td><td rowspan="1" colspan="1">SO3CH3</td><td rowspan="1" colspan="1">H51</td><td rowspan="1" colspan="1">N-OH</td><td rowspan="1" colspan="1">Aniline</td></tr><tr><td rowspan="1" colspan="1">H4</td><td rowspan="1" colspan="1">N-OH</td><td rowspan="1" colspan="1">COCl</td><td rowspan="1" colspan="1">H52</td><td rowspan="1" colspan="1">N-OH</td><td rowspan="1" colspan="1">Indole</td></tr><tr><td rowspan="1" colspan="1">H5</td><td rowspan="1" colspan="1">N-OH</td><td rowspan="1" colspan="1">COOH</td><td rowspan="1" colspan="1">H53</td><td rowspan="1" colspan="1">N-OH</td><td rowspan="1" colspan="1">Pyridine</td></tr><tr><td rowspan="1" colspan="1">H6</td><td rowspan="1" colspan="1">N-OH</td><td rowspan="1" colspan="1">COCH3</td><td rowspan="1" colspan="1">H54</td><td rowspan="1" colspan="1">N-OH</td><td rowspan="1" colspan="1">pyrimidine</td></tr><tr><td rowspan="1" colspan="1">H7</td><td rowspan="1" colspan="1">N-OH</td><td rowspan="1" colspan="1">COH</td><td rowspan="1" colspan="1">H55</td><td rowspan="1" colspan="1">N-CH3</td><td rowspan="1" colspan="1">pyrrole</td></tr><tr><td rowspan="1" colspan="1">H8</td><td rowspan="1" colspan="1">N-OH</td><td rowspan="1" colspan="1">Br</td><td rowspan="1" colspan="1">H56</td><td rowspan="1" colspan="1">N-CH3</td><td rowspan="1" colspan="1">furan</td></tr><tr><td rowspan="1" colspan="1">H9</td><td rowspan="1" colspan="1">N-OH</td><td rowspan="1" colspan="1">Cl</td><td rowspan="1" colspan="1">H57</td><td rowspan="1" colspan="1">N-CH3</td><td rowspan="1" colspan="1">thiophene</td></tr><tr><td rowspan="1" colspan="1">H10</td><td rowspan="1" colspan="1">N-OH</td><td rowspan="1" colspan="1">F</td><td rowspan="1" colspan="1">H58</td><td rowspan="1" colspan="1">N-CH3</td><td rowspan="1" colspan="1">Imidazole</td></tr><tr><td rowspan="1" colspan="1">H11</td><td rowspan="1" colspan="1">N-CH3</td><td rowspan="1" colspan="1">NO2</td><td rowspan="1" colspan="1">H59</td><td rowspan="1" colspan="1">N-CH3</td><td rowspan="1" colspan="1">Oxazole</td></tr><tr><td rowspan="1" colspan="1">H12</td><td rowspan="1" colspan="1">N-CH3</td><td rowspan="1" colspan="1">NCH3</td><td rowspan="1" colspan="1">H60</td><td rowspan="1" colspan="1">N-CH3</td><td rowspan="1" colspan="1">Isooxzole</td></tr><tr><td rowspan="1" colspan="1">H13</td><td rowspan="1" colspan="1">N-CH3</td><td rowspan="1" colspan="1">SO3CH3</td><td rowspan="1" colspan="1">H61</td><td rowspan="1" colspan="1">N-CH3</td><td rowspan="1" colspan="1">Benzene</td></tr><tr><td rowspan="1" colspan="1">H14</td><td rowspan="1" colspan="1">N-CH3</td><td rowspan="1" colspan="1">COCl</td><td rowspan="1" colspan="1">H62</td><td rowspan="1" colspan="1">N-CH3</td><td rowspan="1" colspan="1">Ph-NO2</td></tr><tr><td rowspan="1" colspan="1">H15</td><td rowspan="1" colspan="1">N-CH3</td><td rowspan="1" colspan="1">COOR</td><td rowspan="1" colspan="1">H63</td><td rowspan="1" colspan="1">N-CH3</td><td rowspan="1" colspan="1">Ph-COCH3</td></tr><tr><td rowspan="1" colspan="1">H16</td><td rowspan="1" colspan="1">N-CH3</td><td rowspan="1" colspan="1">COR</td><td rowspan="1" colspan="1">H64</td><td rowspan="1" colspan="1">N-CH3</td><td rowspan="1" colspan="1">Ph-CCl3</td></tr><tr><td rowspan="1" colspan="1">H17</td><td rowspan="1" colspan="1">N-CH3</td><td rowspan="1" colspan="1">COH</td><td rowspan="1" colspan="1">H65</td><td rowspan="1" colspan="1">N-CH3</td><td rowspan="1" colspan="1">Aniline</td></tr><tr><td rowspan="1" colspan="1">H18</td><td rowspan="1" colspan="1">N-CH3</td><td rowspan="1" colspan="1">Br</td><td rowspan="1" colspan="1">H66</td><td rowspan="1" colspan="1">N-CH3</td><td rowspan="1" colspan="1">Indole</td></tr><tr><td rowspan="1" colspan="1">H19</td><td rowspan="1" colspan="1">N-CH3</td><td rowspan="1" colspan="1">Cl</td><td rowspan="1" colspan="1">H67</td><td rowspan="1" colspan="1">N-CH3</td><td rowspan="1" colspan="1">Pyridine</td></tr><tr><td rowspan="1" colspan="1">H20</td><td rowspan="1" colspan="1">N-CH3</td><td rowspan="1" colspan="1">F</td><td rowspan="1" colspan="1">H68</td><td rowspan="1" colspan="1">N-CH3</td><td rowspan="1" colspan="1">pyrimidine</td></tr><tr><td rowspan="1" colspan="1">H21</td><td rowspan="1" colspan="1">N-CH=CH2</td><td rowspan="1" colspan="1">NO2</td><td rowspan="1" colspan="1">H69</td><td rowspan="1" colspan="1">N-CH=CH2</td><td rowspan="1" colspan="1">pyrrole</td></tr><tr><td rowspan="1" colspan="1">H22</td><td rowspan="1" colspan="1">N-CH=CH2</td><td rowspan="1" colspan="1">NCH3</td><td rowspan="1" colspan="1">H70</td><td rowspan="1" colspan="1">N-CH=CH2</td><td rowspan="1" colspan="1">furan</td></tr><tr><td rowspan="1" colspan="1">H23</td><td rowspan="1" colspan="1">N-CH=CH2</td><td rowspan="1" colspan="1">SO3CH3</td><td rowspan="1" colspan="1">H71</td><td rowspan="1" colspan="1">N-CH=CH2</td><td rowspan="1" colspan="1">thiophene</td></tr><tr><td rowspan="1" colspan="1">H24</td><td rowspan="1" colspan="1">N-CH=CH2</td><td rowspan="1" colspan="1">COCl</td><td rowspan="1" colspan="1">H72</td><td rowspan="1" colspan="1">N-CH=CH2</td><td rowspan="1" colspan="1">Imidazole</td></tr><tr><td rowspan="1" colspan="1">H25</td><td rowspan="1" colspan="1">N-CH=CH2</td><td rowspan="1" colspan="1">COOR</td><td rowspan="1" colspan="1">H73</td><td rowspan="1" colspan="1">N-CH=CH2</td><td rowspan="1" colspan="1">Oxazole</td></tr><tr><td rowspan="1" colspan="1">H26</td><td rowspan="1" colspan="1">N-CH=CH2</td><td rowspan="1" colspan="1">COR</td><td rowspan="1" colspan="1">H74</td><td rowspan="1" colspan="1">N-CH=CH2</td><td rowspan="1" colspan="1">Isooxzole</td></tr><tr><td rowspan="1" colspan="1">H27</td><td rowspan="1" colspan="1">N-CH=CH2</td><td rowspan="1" colspan="1">COH</td><td rowspan="1" colspan="1">H75</td><td rowspan="1" colspan="1">N-CH=CH2</td><td rowspan="1" colspan="1">Benzene</td></tr><tr><td rowspan="1" colspan="1">H28</td><td rowspan="1" colspan="1">N-CH=CH2</td><td rowspan="1" colspan="1">Br</td><td rowspan="1" colspan="1">H76</td><td rowspan="1" colspan="1">N-CH=CH2</td><td rowspan="1" colspan="1">Ph-NO2</td></tr><tr><td rowspan="1" colspan="1">H29</td><td rowspan="1" colspan="1">N-CH=CH2</td><td rowspan="1" colspan="1">Cl</td><td rowspan="1" colspan="1">H77</td><td rowspan="1" colspan="1">N-CH=CH2</td><td rowspan="1" colspan="1">Ph-COCH3</td></tr><tr><td rowspan="1" colspan="1">H30</td><td rowspan="1" colspan="1">N-CH=CH2</td><td rowspan="1" colspan="1">F</td><td rowspan="1" colspan="1">H78</td><td rowspan="1" colspan="1">N-CH=CH2</td><td rowspan="1" colspan="1">Ph-CCl3</td></tr><tr><td rowspan="1" colspan="1">H31</td><td rowspan="1" colspan="1">N-Ph</td><td rowspan="1" colspan="1">NO2</td><td rowspan="1" colspan="1">H79</td><td rowspan="1" colspan="1">N-CH=CH2</td><td rowspan="1" colspan="1">Aniline</td></tr><tr><td rowspan="1" colspan="1">H32</td><td rowspan="1" colspan="1">N-Ph</td><td rowspan="1" colspan="1">NCH3</td><td rowspan="1" colspan="1">H80</td><td rowspan="1" colspan="1">N-CH=CH2</td><td rowspan="1" colspan="1">Indole</td></tr><tr><td rowspan="1" colspan="1">H33</td><td rowspan="1" colspan="1">N-Ph</td><td rowspan="1" colspan="1">SO3CH3</td><td rowspan="1" colspan="1">H81</td><td rowspan="1" colspan="1">N-CH=CH2</td><td rowspan="1" colspan="1">Pyridine</td></tr><tr><td rowspan="1" colspan="1">H34</td><td rowspan="1" colspan="1">N-Ph</td><td rowspan="1" colspan="1">COCl</td><td rowspan="1" colspan="1">H82</td><td rowspan="1" colspan="1">N-CH=CH2</td><td rowspan="1" colspan="1">pyrimidine</td></tr><tr><td rowspan="1" colspan="1">H35</td><td rowspan="1" colspan="1">N-Ph</td><td rowspan="1" colspan="1">COOR</td><td rowspan="1" colspan="1">H83</td><td rowspan="1" colspan="1">N-Ph</td><td rowspan="1" colspan="1">pyrrole</td></tr><tr><td rowspan="1" colspan="1">H36</td><td rowspan="1" colspan="1">N-Ph</td><td rowspan="1" colspan="1">COR</td><td rowspan="1" colspan="1">H84</td><td rowspan="1" colspan="1">N-Ph</td><td rowspan="1" colspan="1">furan</td></tr><tr><td rowspan="1" colspan="1">H37</td><td rowspan="1" colspan="1">N-Ph</td><td rowspan="1" colspan="1">COH</td><td rowspan="1" colspan="1">H85</td><td rowspan="1" colspan="1">N-Ph</td><td rowspan="1" colspan="1">thiophene</td></tr><tr><td rowspan="1" colspan="1">H38</td><td rowspan="1" colspan="1">N-Ph</td><td rowspan="1" colspan="1">Br</td><td rowspan="1" colspan="1">H86</td><td rowspan="1" colspan="1">N-Ph</td><td rowspan="1" colspan="1">Imidazole</td></tr><tr><td rowspan="1" colspan="1">H39</td><td rowspan="1" colspan="1">N-Ph</td><td rowspan="1" colspan="1">Cl</td><td rowspan="1" colspan="1">H87</td><td rowspan="1" colspan="1">N-Ph</td><td rowspan="1" colspan="1">Oxazole</td></tr><tr><td rowspan="1" colspan="1">H40</td><td rowspan="1" colspan="1">N-Ph</td><td rowspan="1" colspan="1">F</td><td rowspan="1" colspan="1">H88</td><td rowspan="1" colspan="1">N-Ph</td><td rowspan="1" colspan="1">Isooxzole</td></tr><tr><td rowspan="1" colspan="1">H41</td><td rowspan="1" colspan="1">N-OH</td><td rowspan="1" colspan="1">Pyrrole</td><td rowspan="1" colspan="1">H89</td><td rowspan="1" colspan="1">N-Ph</td><td rowspan="1" colspan="1">Benzene</td></tr><tr><td rowspan="1" colspan="1">H42</td><td rowspan="1" colspan="1">N-OH</td><td rowspan="1" colspan="1">Furan</td><td rowspan="1" colspan="1">H90</td><td rowspan="1" colspan="1">N-Ph</td><td rowspan="1" colspan="1">Ph-NO2</td></tr><tr><td rowspan="1" colspan="1">H43</td><td rowspan="1" colspan="1">N-OH</td><td rowspan="1" colspan="1">thiophene</td><td rowspan="1" colspan="1">H91</td><td rowspan="1" colspan="1">N-Ph</td><td rowspan="1" colspan="1">Ph-COCH3</td></tr><tr><td rowspan="1" colspan="1">H44</td><td rowspan="1" colspan="1">N-OH</td><td rowspan="1" colspan="1">Imidazole</td><td rowspan="1" colspan="1">H92</td><td rowspan="1" colspan="1">N-Ph</td><td rowspan="1" colspan="1">Ph-CCl3</td></tr><tr><td rowspan="1" colspan="1">H45</td><td rowspan="1" colspan="1">N-OH</td><td rowspan="1" colspan="1">Oxazole</td><td rowspan="1" colspan="1">H93</td><td rowspan="1" colspan="1">N-Ph</td><td rowspan="1" colspan="1">Aniline</td></tr><tr><td rowspan="1" colspan="1">H46</td><td rowspan="1" colspan="1">N-OH</td><td rowspan="1" colspan="1">Isooxzole</td><td rowspan="1" colspan="1">H94</td><td rowspan="1" colspan="1">N-Ph</td><td rowspan="1" colspan="1">Indole</td></tr><tr><td rowspan="1" colspan="1">H47</td><td rowspan="1" colspan="1">N-OH</td><td rowspan="1" colspan="1">Benzene</td><td rowspan="1" colspan="1">H95</td><td rowspan="1" colspan="1">N-Ph</td><td rowspan="1" colspan="1">Pyridine</td></tr><tr><td rowspan="1" colspan="1">H48</td><td rowspan="1" colspan="1">N-OH</td><td rowspan="1" colspan="1">Ph-NO2</td><td rowspan="1" colspan="1">H96</td><td rowspan="1" colspan="1">N-Ph</td><td rowspan="1" colspan="1">pyrimidine</td></tr></tbody></table></table-wrap><table-wrap id="T2" position="float"><label>Table 2</label><caption><title>LibDock, Binding energy and H-bond interactions of hydroxamic acids</title></caption><table frame="hsides" rules="groups"><thead><tr><td rowspan="1" colspan="1">Comp</td><td rowspan="1" colspan="1">LibDock Score</td><td rowspan="1" colspan="1">Binding Energy (Kcal/mol)</td><td rowspan="1" colspan="1">H-Bonds</td><td rowspan="1" colspan="1">H-Bond Monitor</td><td rowspan="1" colspan="1">H-Bond distance</td></tr></thead><tbody><tr><td rowspan="1" colspan="1">SAHA</td><td rowspan="1" colspan="1">126.37</td><td rowspan="1" colspan="1">-33.25</td><td rowspan="1" colspan="1">ARG39(2), HIS183, GLY305, GLY154</td><td rowspan="1" colspan="1">P:ARG39:HH21 -L:O19</td><td rowspan="1" colspan="1">2.40, 2.14, 2.18, 2.46, 1.92</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">P:ARG39:HH22 - L:O18</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">P:HIS183:HD1 - L:O10</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">P:GLY305:HN - L:O18</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">L:H25 - P:GLY154:O</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">H32</td><td rowspan="1" colspan="1">162.45</td><td rowspan="1" colspan="1">-18.78</td><td rowspan="1" colspan="1">ARG39, GLY142</td><td rowspan="1" colspan="1">P: ARG39: HH22 - L:O9</td><td rowspan="1" colspan="1">2.40, 2.18</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">L:H31 - P:GLY142:O</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">H51</td><td rowspan="1" colspan="1">153.359</td><td rowspan="1" colspan="1">-30.16</td><td rowspan="1" colspan="1">HIS183, ASP181(2), TYR209, LEU276</td><td rowspan="1" colspan="1">P:HIS183:HD1 - L:O10</td><td rowspan="1" colspan="1">2.24, 2.12, 2.18, 1.78, 2.49</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">L:H33 - P:ASP181:OD1</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">L:H33 - P:ASP181:OD2</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">L:H45 - P:TYR209:OH</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">L:H45 - P:LEU276:O</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">H34</td><td rowspan="1" colspan="1">153.221</td><td rowspan="1" colspan="1">-39.53</td><td rowspan="1" colspan="1">ARG39, HIS146, GLY142</td><td rowspan="1" colspan="1">P: ARG39:HH22 - L:O10</td><td rowspan="1" colspan="1">2.34, 2.20, 2.00</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">L:H28 - P:HIS146:NE2</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">L:H30 - P:GLY142:O</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">H36</td><td rowspan="1" colspan="1">152.171</td><td rowspan="1" colspan="1">-36.9</td><td rowspan="1" colspan="1">TYR29(2), HIS183, TYR29</td><td rowspan="1" colspan="1">P:TYR29:HH - L:O9</td><td rowspan="1" colspan="1">2.31, 1.72, 2.04</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">P:HIS183:HD1 - L:O8</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">L:H30 - P:TYR29:OH</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">H53</td><td rowspan="1" colspan="1">147.078</td><td rowspan="1" colspan="1">-39.72</td><td rowspan="1" colspan="1">ARG39, GLY305, HIS146,</td><td rowspan="1" colspan="1">P:ARG39:HH21 - L:O18</td><td rowspan="1" colspan="1">1.75, 2.12, 2.07, 2.39, 1.88</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">GLY142(2)</td><td rowspan="1" colspan="1">P:GLY305:HN - L:O19</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">L:H30 - P:HIS146:NE2</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">L:H43 - P:GLY142:O</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">L: H44 - P:GLY142:O</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">H81</td><td rowspan="1" colspan="1">145.945</td><td rowspan="1" colspan="1">-56.08</td><td rowspan="1" colspan="1">ARG39, TYR308, HIS146</td><td rowspan="1" colspan="1">P:ARG39:HH21 - L:N5</td><td rowspan="1" colspan="1">1.81, 2.34, 2.03</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">P:TYR308:HH - L:O9</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">L:H29 - P:HIS146:NE2</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">H43</td><td rowspan="1" colspan="1">145.859</td><td rowspan="1" colspan="1">-45.1</td><td rowspan="1" colspan="1">ARG39, GLN265(2), HIS145, ASP181, ASP104</td><td rowspan="1" colspan="1">P:ARG39:HH21 - L:S24</td><td rowspan="1" colspan="1">2.44, 2.46, 2.14, 2.40, 2.07, 1.89</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">P:GLN265:HE21 - L:O10</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">P:GLN265:HE22 - L:O10</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">L:H31 - P:HIS145:NE2</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">L:H31 - P:ASP181:OD1</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">L:H43 - P:ASP104:OD2</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">H72</td><td rowspan="1" colspan="1">145.32</td><td rowspan="1" colspan="1">-10.3</td><td rowspan="1" colspan="1">HIS183, TYR308</td><td rowspan="1" colspan="1">L:H26 - P:HIS183:NE2</td><td rowspan="1" colspan="1">2.15, 2.02</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">L:H27 - P:TYR308:OH</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">H67</td><td rowspan="1" colspan="1">144.667</td><td rowspan="1" colspan="1">-8.4</td><td rowspan="1" colspan="1">HIS183, GLY154</td><td rowspan="1" colspan="1">P: HIS183:HD1 - L: O9</td><td rowspan="1" colspan="1">2.37, 1.91</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">L: H26 - P: GLY154:O</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">H74</td><td rowspan="1" colspan="1">144.355</td><td rowspan="1" colspan="1">-5.02</td><td rowspan="1" colspan="1">ARG39, GLY305, GLY154, GLY142</td><td rowspan="1" colspan="1">P: ARG39:HH21 - L: N14</td><td rowspan="1" colspan="1">2.29, 2.49, 1.92, 1.73</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">P: GLY305: HN - L:O13</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">L:H27 - P:GLY154:O</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">L: H30 - P: GLY142:O</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">H54</td><td rowspan="1" colspan="1">144.304</td><td rowspan="1" colspan="1">-33.57</td><td rowspan="1" colspan="1">ARG39, GLN265, GLY306, ASP181</td><td rowspan="1" colspan="1">P:ARG39:HH21 - L:N25</td><td rowspan="1" colspan="1">2.36, 2.35, 2.37, 1.90, 1.93</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">P:GLN265:HE22 - L:O10</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">P:GLY306:HN - L:O10</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">L:H32 - P:ASP181:OD1</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">H27</td><td rowspan="1" colspan="1">144.161</td><td rowspan="1" colspan="1">-40.78</td><td rowspan="1" colspan="1">ARG39(3), HIS183(2), GLY305, GLY142</td><td rowspan="1" colspan="1">P:ARG39:HH21 -L:N7</td><td rowspan="1" colspan="1">2.27, 2.40, 2.45, 2.40, 1.95, 2.44, 1.74</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">P:ARG39:HH22 - L:O9</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">P:ARG39:HH22 - L:O6</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">P:HIS183:HD1 - L:O8</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">P:HIS183:HD1 - L:O5</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">P:GLY305:HN - L:O6</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">L:H24 - P:GLY142:O</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">H46</td><td rowspan="1" colspan="1">143.584</td><td rowspan="1" colspan="1">-26.2</td><td rowspan="1" colspan="1">ARG39, HIS145, GLY143, ASP104</td><td rowspan="1" colspan="1">P: ARG39:HH21 - L: N24</td><td rowspan="1" colspan="1">2.36, 2.46, 1.80, 2.21</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">P: HIS145: HN - L: O10</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">L: H31 - P:GLY143:O</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">L:H43 - P:ASP104:OD2</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">H37</td><td rowspan="1" colspan="1">143.211</td><td rowspan="1" colspan="1">-2.03</td><td rowspan="1" colspan="1">ARG39 (2)</td><td rowspan="1" colspan="1">P:ARG39:HH21 - L:O6</td><td rowspan="1" colspan="1">2.31, 2.12</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">P:ARG39:HH22 - L:O6</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">H30</td><td rowspan="1" colspan="1">143.005</td><td rowspan="1" colspan="1">-35.76</td><td rowspan="1" colspan="1">ARG39(2), HIS183, GLY305, TRP140</td><td rowspan="1" colspan="1">P:ARG39:HH21 - L:N8</td><td rowspan="1" colspan="1">2.16, 2.45, 2.13, 2.18, 1.85</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">P:ARG39:HH22 - L:O7</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">P:HIS183:HD1 - L:O6</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">P:GLY305:HN - L:O7</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">L:H24 - P:TRP140:O</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">H26</td><td rowspan="1" colspan="1">142.892</td><td rowspan="1" colspan="1">-26.98</td><td rowspan="1" colspan="1">ARG39, GLY305, TYR308, GLY142</td><td rowspan="1" colspan="1">P:ARG39:HH21 - L:N11</td><td rowspan="1" colspan="1">2.20, 2.40, 1.97, 1.73</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">P:GLY305:HN - L:O9</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">L:H24 - P:TYR308:OH</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">L:H26 - P:GLY142:O</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">H47</td><td rowspan="1" colspan="1">142.128</td><td rowspan="1" colspan="1">-36.92</td><td rowspan="1" colspan="1">GLN265, GLY306, ASP181, ASP104</td><td rowspan="1" colspan="1">P:GLN265:HE22 - L:O10</td><td rowspan="1" colspan="1">2.45, 2.38, 2.05, 1.84</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">P:GLY306:HN - L:O10</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">L:H32 - P:ASP181:OD1</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">L:H44 - P:ASP104:OD2</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">H3</td><td rowspan="1" colspan="1">141.334</td><td rowspan="1" colspan="1">-20.6</td><td rowspan="1" colspan="1">ARG39, TYR308, HIS183</td><td rowspan="1" colspan="1">P:ARG39:HH21 - L:O22</td><td rowspan="1" colspan="1">1.75, 1.92, 2.09</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">P:TYR308:HH - L:O10</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">L:H42 - P:HIS183:NE2</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">H69</td><td rowspan="1" colspan="1">141.308</td><td rowspan="1" colspan="1">-8.06</td><td rowspan="1" colspan="1">TYR308, ALA141</td><td rowspan="1" colspan="1">P:TYR308:HH - L:O12</td><td rowspan="1" colspan="1">2.17, 1.84</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">L:H26 - P:ALA141:O</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">H44</td><td rowspan="1" colspan="1">141.29</td><td rowspan="1" colspan="1">-57.1</td><td rowspan="1" colspan="1">ARG39, TYR308, GLY142, ALA141, HIS183</td><td rowspan="1" colspan="1">P:ARG39:HH21 - L:O18</td><td rowspan="1" colspan="1">2.18, 1.93, 2.21, 1.82, 2.08</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">L:H29 - P:TYR308:OH</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">L:H42 - P:GLY142:O</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">L:H43 - P:ALA141:O</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">L:H46 - P:HIS183:NE2</td><td rowspan="1" colspan="1"/></tr></tbody></table></table-wrap><table-wrap id="T3" position="float"><label>Table 3</label><caption><title>ADMET prediction of top 20 optimized compounds</title></caption><table frame="hsides" rules="groups"><thead><tr><td rowspan="1" colspan="1">Compound </td><td rowspan="1" colspan="1">aAbsorption</td><td rowspan="1" colspan="1">bBBB Level</td><td rowspan="1" colspan="1">cCYP2D6</td><td rowspan="1" colspan="1">dHepatotoxicity</td></tr></thead><tbody><tr><td rowspan="1" colspan="1">Compound 3</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">4</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">0.509</td></tr><tr><td rowspan="1" colspan="1">Compound 26</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">3</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">0.536</td></tr><tr><td rowspan="1" colspan="1">Compound 27</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">3</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">0.509</td></tr><tr><td rowspan="1" colspan="1">Compound 30</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">0.476</td></tr><tr><td rowspan="1" colspan="1">Compound 32</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">0.582</td></tr><tr><td rowspan="1" colspan="1">Compound 34</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">0.701</td></tr><tr><td rowspan="1" colspan="1">Compound 36</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">0.688</td></tr><tr><td rowspan="1" colspan="1">Compound 37</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">0.642</td></tr><tr><td rowspan="1" colspan="1">Compound 43</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">0.602</td></tr><tr><td rowspan="1" colspan="1">Compound 44</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">3</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">0.49</td></tr><tr><td rowspan="1" colspan="1">Compound 46</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">3</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">0.437</td></tr><tr><td rowspan="1" colspan="1">Compound 47</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">0.662</td></tr><tr><td rowspan="1" colspan="1">Compound 51</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">4</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">0.682</td></tr><tr><td rowspan="1" colspan="1">Compound 53</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">3</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">0.682</td></tr><tr><td rowspan="1" colspan="1">Compound 54</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">3</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">0.655</td></tr><tr><td rowspan="1" colspan="1">Compound 67</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">0.509</td></tr><tr><td rowspan="1" colspan="1">Compound 69</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">0.596</td></tr><tr><td rowspan="1" colspan="1">Compound 72</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">3</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">0.503</td></tr><tr><td rowspan="1" colspan="1">Compound 74</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">3</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">0.443</td></tr><tr><td rowspan="1" colspan="1">Compound 810</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">0.649</td></tr></tbody></table></table-wrap><fig id="F1" position="float"><label>Figure 1</label><caption><p>Structural requirement for designing potent hydroxamic
acids inhibitors</p></caption><graphic xlink:href="97320630015380F1"/></fig><fig id="F2" position="float"><label>Figure 2</label><caption><p>Docking poses of top four compounds (a) SAHA (b) (3-(8-oxo-8-(phenylamino)octanamido)benzoyl chloride (H34); (c) N1-(3-
(pyridin-2-yl)phenyl)-N8-vinyloctanediamide (H81); (d) N1-hydroxy-N8-(3-(thiophen-2-yl)phenyl)octanediamide (H43); (e) N1-(3-
fluorophenyl)-N8-vinyloctanediamide) (H30).</p></caption><graphic xlink:href="97320630015380F2"/></fig><fig id="F3" position="float"><label>Figure 3</label><caption><p>Plot of Polar Surface Area (PSA) vs. LogP for a standard
and test set showing the 95% and 99% confidence limit ellipses
corresponding to the Blood Brain Barrier and Intestinal Absorption
models.</p></caption><graphic xlink:href="97320630015380F3"/></fig></floats-group></article>